Key result
PPIs and bivalirudin protect against post-PCI gastrointestinal bleeding, while anemia, older age, and comorbidities increase risk.
Why the study?
To quantitatively analyse factors related to gastrointestinal bleeding after percutaneous coronary intervention and provide evidence for its prevention.
What are the risk and protective factors for gastrointestinal bleeding in patients after percutaneous coronary intervention?
Meta-Analysis
What are the risk and protective factors for gastrointestinal bleeding in patients after percutaneous coronary intervention?
Identifies key clinical risk factors and protective therapies (PPIs and bivalirudin) to help manage and prevent gastrointestinal bleeding after percutaneous coronary intervention.
Aim To quantitatively analyse factors related to gastrointestinal bleeding after percutaneous coronary intervention and provide evidence for the prevention of gastrointestinal bleeding. Data Sources and Review Methods Cochrane Library, Pubmed, Embase, and Ovid databases were searched from inception to 31 May 2018; case‐control and cohort studies published in English were included. The methodological quality of each study was assessed by two independent reviewers using the Newcastle‐Ottawa Scale. Meta‐analysis was performed using Revman version 5.3. Results A total of 16 publications yielded data about risk factors. It was found that age older than 70 years, age (per 10‐year increase), female sex, baseline anaemia, history of smoking, history of using alcohol, history of peptic ulcer disease, chronic renal failure, previous bleeding, shock, congestive heart failure, acute myocardial infarction, prior use of inotropic medications, and prior use of antithrombotic medications were positively associated with gastrointestinal bleeding. Four articles yielded data about protective factors. It was found that proton‐pump inhibitor and bivalirudin therapy were negatively associated with gastrointestinal bleeding after percutaneous coronary intervention. Conclusion This research found risk and protective factors which can assist in effective management of this potentially fatal complication.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2018) conducted a meta-analysis in Gastrointestinal bleeding after percutaneous coronary intervention. Risk factors (e.g., age >70, female sex, anemia, prior ulcer/bleeding, renal/heart failure, AMI, shock) and protective factors (PPIs, bivalirudin) vs. Absence of respective risk or protective factors was evaluated on Gastrointestinal bleeding after percutaneous coronary intervention. Across 16 studies, age >70, anemia, peptic ulcer, and renal/heart failure increased post-PCI gastrointestinal bleeding risk, while PPIs and bivalirudin were protective (4 studies).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: